Lena Gendler-Lapkina
Tel Aviv, TA 69978, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
Journal: Cells
Published: May 04, 2021
Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115-127].
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 17, 2021
Identification of nephronectin as a new target for IGF1 action.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 03, 2020
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.
Journal: Oncotarget
Published: May 16, 2019
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
Journal: Cells
Published: May 11, 2019
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 18, 2018
Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Published: May 20, 2017
Fifty years on: New lessons from Laron syndrome.
Journal: The Israel Medical Association journal : IMAJ
Published: May 01, 2017
Identification of signaling pathways associated with cancer protection in Laron syndrome.
Journal: Endocrine-related cancer
Published: March 29, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026